Literature DB >> 25297666

Commentary on silent renal stones in primary hyperparathyroidism: prevalence and clinical features.

Cristiana Cipriani1, John P Bilezikian2.   

Abstract

Entities:  

Year:  2014        PMID: 25297666      PMCID: PMC4311518          DOI: 10.4158/EP14313.CO

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  15 in total

1.  Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor.

Authors:  Alfredo Scillitani; Vito Guarnieri; Claudia Battista; Simona De Geronimo; Lucia Anna Muscarella; Iacopo Chiodini; Mauro Cignarelli; Salvatore Minisola; Francesco Bertoldo; Cristiano M Francucci; Nazzarena Malavolta; Alessandro Piovesan; Maria Lucia Mascia; Silvana Muscarella; Geoffrey N Hendy; Leonardo D'Agruma; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2006-10-03       Impact factor: 5.958

Review 2.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

3.  Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism.

Authors:  Bian Wu; Philip I Haigh; Roy Hwang; Philip H G Ituarte; In-Lu Amy Liu; Theodore J Hahn; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

4.  Predictors of renal function in primary hyperparathyroidism.

Authors:  Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

5.  Patients with primary hyperparathyroidism--why do some form stones?

Authors:  Aaron D Berger; Wilfred Wu; Brian H Eisner; Matthew R Cooperberg; Quan-Yang Duh; Marshall L Stoller
Journal:  J Urol       Date:  2009-03-17       Impact factor: 7.450

6.  Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Authors:  Barbara Campolina Silva; Stephanie Boutroy; Chiyuan Zhang; Donald Jay McMahon; Bin Zhou; Ji Wang; Julia Udesky; Serge Cremers; Marta Sarquis; Xiang-Dong Edward Guo; Didier Hans; John Paul Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

7.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

8.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

Authors:  John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

9.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

10.  Primary hyperparathyroidism: is there an increased prevalence of renal stone disease?

Authors:  Jane M Suh; John J Cronan; Jack M Monchik
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.